Gynecologic Oncology logo Academic Press logo

Publisher: Academic Press

Related content
Volume 77, Number 1, April 2000

< previous issue | all issues | next issue >

Molecular and Cytokinetic Pretreatment Risk Assessment in Endometrial Carcinoma
pp. 1-7(7)
Authors: Silverman M.B.; Roche P.C.; Kho R.M.; Keeney G.L.; Li H.; Podratz K.C.

Apoptosis, bcl-2 Expression, and Proliferation in Benign and Malignant Endometrial Epithelium: An Approach Using Multiparameter Flow Cytometry
pp. 11-17(7)
Authors: Morsi H.M.; Leers M.P.G.; Radespiel-Tröger M.; Björklund V.; Kabarity H.E.; Nap M.; Jäger W.

Atypical Clustering of Gynecologic Malignancies: A Family Study Including Molecular Analysis of Candidate Genes
pp. 18-25(8)
Authors: Cohn D.E.; Babb S.; Whelan A.J.; Mutch D.G.; Herzog T.J.; Rader J.S.; Elbendary A.; Goodfellow P.J.

Expression of Carbohydrate Antigens in Advanced-Stage Ovarian Carcinomas and Their Metastases—A Clinicopathologic Study
pp. 35-43(9)
Authors: Davidson B.; Gotlieb W.H.; Ben-Baruch G.; Kopolovic J.; Goldberg I.; Nesland J.M.; Berner A.; Bjåmer A.; Bryne M.

The Outcome of Stage I–II Clinically and Surgically Staged Papillary Serous and Clear Cell Endometrial Cancers When Compared with Endometrioid Carcinoma
pp. 55-65(11)
Authors: Cirisano F.D.; Robboy S.J.; Dodge R.K.; Bentley R.C.; Krigman H.R.; Synan I.S.; Soper J.T.; Clarke-Pearson D.L.

Results of Radical Radiotherapy for Recurrent Endometrial Cancer
pp. 66-72(7)
Authors: Wylie J.; Irwin C.; Pintilie M.; Levin W.; Manchul L.; Milosevic M.; Fyles A.

Sexual Dysfunction Following Vulvectomy
pp. 73-77(5)
Authors: Green M.S.; Naumann R.W.; Elliot M.; Hall J.B.; Higgins R.V.; Grigsby J.H.

Combined Transvaginal B-Mode and Color Doppler Sonography for Differential Diagnosis of Ovarian Tumors: Results of a Multivariate Logistic Regression Analysis
pp. 78-86(9)
Authors: Schelling M.; Braun M.; Kuhn W.; Bogner G.; Gruber R.; Gnirs J.; Schneider K.T.; Ulm K.; Rutke S.; Staudach A.

Inguinal Node Status by Ultrasound in Vulva Cancer
pp. 93-96(4)
Authors: Abang Mohammed D.K.; Uberoi R.; de B. Lopes A.; Monaghan J.M.

Rare Activation of the TCF/beta-Catenin Pathway in Ovarian Cancer
pp. 97-104(8)
Authors: Furlong M.T.; Morin P.J.

ras Gene Activation and Infrequent Mutation in Papillary Serous Carcinoma of the Peritoneum
pp. 105-111(7)
Authors: Garrett A.P.; Ng S-W.; Muto M.G.; Welch W.R.; Bell D.A.; Berkowitz R.S.; Mok S.C.

Radiation Therapy for Elderly Patient with Squamous Cell Carcinoma of the Uterine Cervix
pp. 116-120(5)
Authors: Sakurai H.; Mitsuhashi N.; Takahashi M.; Yamakawa M.; Akimoto T.; Hayakawa K.; Niibe H.

Establishment and Characterization of a Breast Cell Strain Containing a BRCA1 185delAG Mutation
pp. 121-128(8)
Authors: Annab L.A.; Terry L.; Cable P.L.A.; Brady J.; Stampfer M.R.; Barrett J.C.; Afshari C.A.

The Possible Role of p53 and bcl-2 Expression in Cervical Carcinomas and Their Premalignant Lesions
pp. 129-136(8)
Authors: Dimitrakakis C.; Kymionis G.; Diakomanolis E.; Papaspyrou I.; Rodolakis A.; Arzimanoglou I.; Leandros E.; Michalas S.

Development and Assessment of a General Theory of Cervical Carcinogenesis Utilizing a Severe Combined Immunodeficiency Murine–Human Xenograft Model
pp. 137-148(12)
Authors: Tewari K.S.; Taylor J.A.; Liao S.Y.; DiSaia P.J.; Burger R.A.; Monk B.J.; Hughes C.C.W.; Villarreal L.P.

Use of Hormone Replacement Therapy and Adenocarcinomas and Squamous Cell Carcinomas of the Uterine Cervix
pp. 149-154(6)
Authors: Lacey J.V.; Brinton L.A.; Barnes W.A.; Gravitt P.E.; Greenberg M.D.; Hadjimichael O.C.; McGowan L.; Mortel R.; Schwartz P.E.; Kurman R.J.; Hildesheim A.

Radical Hysterectomy: An Anatomic Evaluation of Parametrial Dissection
pp. 155-163(9)
Authors: Yabuki Y.; Asamoto A.; Hoshiba T.; Nishimoto H.; Nishikawa Y.; Nakajima T.

Can Initial Serum Cyfra 21-1, SCC Antigen, and TPA Levels in Squamous Cell Cervical Cancer Predict Lymph Node Metastases or Prognosis?
pp. 164-170(7)
Authors: Gaarenstroom K.N.; Kenter G.G.; Bonfrer J.M.G.; Korse C.M.; Van de Vijver M.J.; Fleuren G-J.; Trimbos J.B.

Allelic Imbalance in Lichen Sclerosus, Hyperplasia, and Intraepithelial Neoplasia of the Vulva
pp. 171-176(6)
Authors: Pinto A.P.; Lin M-c.; Sheets E.E.; Muto M.G.; Sun D.; Crum C.P.

Paget's Disease of the Vulva: Pathology, Pattern of Involvement, and Prognosis
pp. 183-189(7)
Authors: Parker L.P.; Parker J.R.; Bodurka-Bevers D.; Deavers M.; Bevers M.W.; Shen-Gunther J.; Gershenson D.M.

Alternative Medicine in Gynecologic Oncology: A Case Report
pp. 190-192(3)
Authors: von Gruenigen V.E.; Hopkins M.P.

High-Dose-Rate Interstitial Brachytherapy of Bartholin's Gland: A Case Report
pp. 193-196(4)
Authors: Yamada T.; Yanagawa S.; Iwai H.; Ishigaki T.; Nawa A.; Kikkawa F.

Complete Hydatidiform Mole and a Coexistent Viable Fetus: Report of Two Cases and Review of the Literature
pp. 197-202(6)
Authors: Bruchim I.; Kidron D.; Amiel A.; Altaras M.; Fejgin M.D.

alpha-Fetoprotein Production by a Malignant Mixed Müllerian Tumor of the Ovary
pp. 203-205(3)
Authors: Rebischung C.; Pautier P.; Morice P.; Lhomme C.; Duvillard P.

Metachronous Carcinoma of the Vulva and Fallopian Tube
pp. 206-209(4)
Authors: Ichikawa Y.; Tsunoda H.; Nishide K.; Nishida M.; Kubo T.

Uterine Metastasis from a Heterologous Metaplastic Breast Carcinoma Simulating a Primary Uterine Malignancy
pp. 216-218(3)
Authors: Sinkre P.; Milchgrub S.; Miller D.S.; Albores-Saavedra J.; Hameed A.

< previous issue | all issues | next issue >

Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content

Text size:

A | A | A | A
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages. print icon Print this page